Designing Therapies for Solid Tumour Indications to Enhance Efficacy in the Microenvironment In Vivo
Time: 3:30 pm
day: Day One
Details:
- Overview of first-in-class learnings for gamma-delta CAR-T cells
- Discuss areas for further leveraging, enhancing, and targeting gamma-delta T cells in solid malignancies
- Reprogramming innate signalling capabilities to augment potency for gammadelta T cells in solid tumours
